Skip to main content
. 2021 Nov 10;11(11):3022. doi: 10.3390/nano11113022

Table 3.

Summary of 99mTc-labeled organic nanoparticles and their applications.

Nanoparticle Application Drug Loaded on NPs Radiolabeling Method Ref.
Dendrimer Human breast cancer (MCF-7) imaging Without drug Chelator-based radiolabeling using HYNIC and stannous chloride (reducing agent) [58]
A549 tumor imaging Without drug Direct radiolabeling using stannous chloride (reducing agent) [59]
Polymeric Nanoparticles General biodistribution study Etoposide Direct radiolabeling using stannous chloride (reducing agent) [60]
Sentinel lymph node Without drug Direct radiolabeling using stannous chloride (reducing agent),chelator-based radiolabeling using DTPA [61]
Comparative study using various reducing agents for 99mTc radiolabeling Without drug Direct radiolabeling using stannous chloride, sodium dithionite or sodium borohydride (reducing agent) [62]
Imaging of folate receptor overexpressed tumors Folic acid Direct radiolabeling using stannous chloride (reducing agent) [63]
Imaging of folate receptor or vascular endothelial growth factor receptor-2 (VEGFR-2) overexpressed tumors Folic acid (FA) to target folate receptor and K237 (HTMYYHHYQHHL) peptide Direct radiolabeling using stannous chloride (reducing agent) [64]
General biodistribution study Gemcitabine Direct radiolabeling using tricarbonyl kit [65]
Lipid nanoparticles Imaging of folate receptor overexpressed tumors Cisplatin and folic acid Direct radiolabeling using stannous chloride (reducing agent) [68]
Bone imaging Methylene diphosphonate (MDP) Direct radiolabeling using stannous chloride (reducing agent) [69]
Liposomes nanoparticles General biodistribution study Without drug Direct radiolabeling on the surface of nanoparticles [71]
General biodistribution study Without drug Chelator-based radiolabeling using 2-Iminothiolane and tricrbonyl kit [72]
Oligomers Human HepG2 cells targeting Folic acid Direct radiolabeling using stannous chloride (reducing agent) [74]
Protein nanoparticles
(Human Serum Albumin)
General biodistribution study Bevacizumab Direct radiolabeling using tricarbonyl kit [77]
General biodistribution study HPMC, GMN2, GPM2 and GTM2 polymer coating Direct radiolabeling using stannous chloride (reducing agent) [78]